לברסט
rafa laboratories ltd - letrozole 2.5 mg - film coated tablets - letrozole - letrozole tablets are indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined locally advanced or metastatic breast cancer. letrozole is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
דיפירון קלצקס 500 מגמל
a.l. medi-market ltd. - metamizole sodium monohydrate - תמיסה להזרקה - metamizole sodium monohydrate 500 mg / 1 ml - metamizole sodium
אומפרה 40
rafa laboratories ltd - omeprazole - קפסולות - omeprazole 40 mg - omeprazole
סולזול
k.s.kim international (sk- pharma) ltd., israel - esomeprazole as sodium - אבקה להמסה להזרקה\אינפוזיה - esomeprazole as sodium 40 mg/vial - esomeprazole
אסופרים קונטרול 20 מג
k.s.kim international (sk- pharma) ltd., israel - esomeprazole as sodium - קפסולה קשיחה - esomeprazole as sodium 20 mg - esomeprazole
אזומפרזול מדי מרקט 40 מג
a.l. medi-market ltd. - esomeprazole as sodium - אבקה להמסה להזרקה\אינפוזיה - esomeprazole as sodium 40 mg/vial - esomeprazole
פמוזול
perrigo israel agencies ltd - letrozole 2.5 mg - film coated tablets - letrozole - • femozol (letrozole tablets) is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer . • femozol is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy .• extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy .• adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer .
לטרוזול אינובמד 2.5 מ"ג
inovamed ltd - letrozole 2.5 mg - film coated tablets - letrozole - for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined locally advanced or metastatic breast cancer. for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy.adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.
אנסטרוז
taro international ltd - anastrozole 1 mg - tablets - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.
אנסטרוזול מדיטק 1 מ"ג
sam-on ltd - anastrozole 1 mg - film coated tablets - anastrozole - treatment of advanced breast cancer in post menopausal women. efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.